This inventor holds 1 USPTO granted patent. Top assignee: Merck Frosst Canada, Inc.. Active years: 1997.
Company Filing History:
Years Active: 1997
Title: The Innovations of Pamela Zabel
Introduction
Pamela Zabel is a notable inventor based in St. Mary's, California. She has made significant contributions to the field of medical imaging through her innovative work on angiotensin converting enzyme (ACE) inhibitors. Her research has implications for diagnosing and treating various diseases, showcasing her expertise and dedication to advancing healthcare.
Latest Patents
Pamela Zabel holds a patent for "Radiolabelled angiotensin converting enzyme inhibitors." This invention involves labelling ACE inhibitors with isotopes such as Iodine-123, Iodine-125, Iodine-127, or Iodine-131. These labelled compounds are useful for imaging the kidneys and lungs, aiding in the diagnosis and treatment of conditions like essential hypertension, renal artery stenosis, and diabetes, which are associated with changes in ACE levels in the human body. She has 1 patent to her name.
Career Highlights
Zabel is currently employed at Merck Frosst Canada, Inc., where she continues to work on innovative solutions in the pharmaceutical industry. Her career reflects a commitment to improving patient outcomes through scientific research and development.
Collaborations
Throughout her career, Pamela has collaborated with esteemed colleagues, including Richard J. Flanagan and Duncan H. Hunter. These partnerships have contributed to her success and the advancement of her research.
Conclusion
Pamela Zabel's contributions to the field of medical imaging and her innovative patent on ACE inhibitors highlight her role as a significant inventor in healthcare. Her work continues to impact the diagnosis and treatment of critical health conditions.